User login
Medical Education Library
A Best Practices Supplement to Skin & Allergy News®. This supplement was sponsored by Valeant Pharmaceuticals North America LLC.
- Introduction
- Carac Cream (fluorouracil cream) 0.5%
- Zyclara (imiquimod) Cream 2.5% and 3.75%
- Summary
- IMPORTANT SAFETY INFORMATION
Faculty/Faculty Disclosure
Dr. Harper, MD
Clinical Associate Professor of Dermatology University of Alabama-Birmingham Dermatology and Skin Care Center of Birmingham, P.C.
Birmingham, Alabama
Dr. Harper reported that she is a consultant and speaker for Medicis Pharmaceutical Corporation, a division of Valeant Pharmaceuticals, and received compensation from Valeant for her assistance in developing the content of this article.
LINKS: Click Here for PDF.
Copyright © by Frontline Medical Communications Inc.
Medical Education Library
A Best Practices Supplement to Skin & Allergy News®. This supplement was sponsored by Valeant Pharmaceuticals North America LLC.
- Introduction
- Carac Cream (fluorouracil cream) 0.5%
- Zyclara (imiquimod) Cream 2.5% and 3.75%
- Summary
- IMPORTANT SAFETY INFORMATION
Faculty/Faculty Disclosure
Dr. Harper, MD
Clinical Associate Professor of Dermatology University of Alabama-Birmingham Dermatology and Skin Care Center of Birmingham, P.C.
Birmingham, Alabama
Dr. Harper reported that she is a consultant and speaker for Medicis Pharmaceutical Corporation, a division of Valeant Pharmaceuticals, and received compensation from Valeant for her assistance in developing the content of this article.
LINKS: Click Here for PDF.
Copyright © by Frontline Medical Communications Inc.
Medical Education Library
A Best Practices Supplement to Skin & Allergy News®. This supplement was sponsored by Valeant Pharmaceuticals North America LLC.
- Introduction
- Carac Cream (fluorouracil cream) 0.5%
- Zyclara (imiquimod) Cream 2.5% and 3.75%
- Summary
- IMPORTANT SAFETY INFORMATION
Faculty/Faculty Disclosure
Dr. Harper, MD
Clinical Associate Professor of Dermatology University of Alabama-Birmingham Dermatology and Skin Care Center of Birmingham, P.C.
Birmingham, Alabama
Dr. Harper reported that she is a consultant and speaker for Medicis Pharmaceutical Corporation, a division of Valeant Pharmaceuticals, and received compensation from Valeant for her assistance in developing the content of this article.
LINKS: Click Here for PDF.
Copyright © by Frontline Medical Communications Inc.
